BUD vs IRIX
BUD (BUD) versus IRIDEX Corporation (IRIX) — a side-by-side from cached financials, not a winner call.
BUD (BUD) common stock.
IRIDEX Corporation (IRIX) is a medical devices company listed on US.
BUD does not have a complete income-statement cache yet.
Latest reported IRIX revenue for 2026-07-04 was $12.6M. Net income was -$1.3M. Revenue was up 6.5% from 2026-04-04 to 2026-07-04. IRIX currently screens at market cap $19.0M.
BUD currently screens at market cap $0. IRIX currently screens at market cap $19.0M.
Not investment advice. Open the BUD and IRIX stock pages for the full models.
Not investment advice.